171 related articles for article (PubMed ID: 3280183)
1. Biological properties of human C5a: selected in vitro and in vivo studies.
Yancey KB
Clin Exp Immunol; 1988 Feb; 71(2):207-10. PubMed ID: 3280183
[No Abstract] [Full Text] [Related]
2. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
Gerard C; Hugli TE
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
[TBL] [Abstract][Full Text] [Related]
3. C5 neoepitopes appearing during activation.
Inoue K
Complement Inflamm; 1989; 6(3):219-22. PubMed ID: 2472923
[TBL] [Abstract][Full Text] [Related]
4. The chemoattractant des-Arg74-C5a regulates the expression of its own receptor on a monocyte-like cell line.
Barker MD; Jose PJ; Williams TJ; Burton DR
Biochem J; 1986 Jun; 236(2):621-4. PubMed ID: 3019322
[TBL] [Abstract][Full Text] [Related]
5. The C5a receptor of neutrophils and macrophages.
Chenoweth DE; Goodman MG
Agents Actions Suppl; 1983; 12():252-73. PubMed ID: 6573117
[No Abstract] [Full Text] [Related]
6. Inflammatory properties of human C5a and C5a des Arg/ in mast cell-depleted human skin.
Swerlick RA; Yancey KB; Lawley TJ
J Invest Dermatol; 1989 Sep; 93(3):417-22. PubMed ID: 2527912
[TBL] [Abstract][Full Text] [Related]
7. Requirements for C5a receptor-mediated IL-4 and IL-13 production and leukotriene C4 generation in human basophils.
Eglite S; Plüss K; Dahinden CA
J Immunol; 2000 Aug; 165(4):2183-9. PubMed ID: 10925305
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of loss of human neutrophil chemotaxis following thermal injury.
Nelson RD; Hasslen SR; Ahrenholz DH; Solem LD
J Burn Care Rehabil; 1987; 8(6):496-502. PubMed ID: 3436972
[TBL] [Abstract][Full Text] [Related]
9. A direct in vivo comparison of the inflammatory properties of human C5a and C5a des Arg in human skin.
Swerlick RA; Yancey KB; Lawley TJ
J Immunol; 1988 Apr; 140(7):2376-81. PubMed ID: 3351304
[TBL] [Abstract][Full Text] [Related]
10. [Immunologic defense mechanism of complement-derived inflammatory chemical mediators].
Yamamoto T; Kambara T
Nihon Rinsho; 1988 Sep; 46(9):1974-80. PubMed ID: 3266512
[No Abstract] [Full Text] [Related]
11. Purification of human C5a des arg by immunoadsorbent and molecular sieve chromatography.
Manderino GL; Suarez AF; Kunkel SL; Ward PA; Hirata AA; Showell H
J Immunol Methods; 1982 Aug; 53(1):41-50. PubMed ID: 6752282
[TBL] [Abstract][Full Text] [Related]
12. A specific enzyme-linked immunosorbent assay (ELISA) for the determination of human C5a antigen.
Kunkel SL; Manderino GL; Marasco W; Kaercher K; Hirata AA; Ward PA
J Immunol Methods; 1983 Sep; 62(3):305-14. PubMed ID: 6193199
[TBL] [Abstract][Full Text] [Related]
13. Rapid and simple measurement of human C5a-des-Arg level in plasma or serum using monoclonal antibodies.
Takeda J; Kinoshita T; Takata Y; Kozono H; Tanaka E; Hong K; Inoue K
J Immunol Methods; 1987 Aug; 101(2):265-70. PubMed ID: 3611800
[TBL] [Abstract][Full Text] [Related]
14. Human C5a and C5a des Arg exhibit chemotactic activity for fibroblasts.
Senior RM; Griffin GL; Perez HD; Webster RO
J Immunol; 1988 Nov; 141(10):3570-4. PubMed ID: 3183381
[TBL] [Abstract][Full Text] [Related]
15. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
Oppermann M; Götze O
Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
[TBL] [Abstract][Full Text] [Related]
16. Anaphylatoxin-mediated regulation of the immune response. II. C5a-mediated enhancement of human humoral and T cell-mediated immune responses.
Morgan EL; Thoman ML; Weigle WO; Hugli TE
J Immunol; 1983 Mar; 130(3):1257-61. PubMed ID: 6600480
[TBL] [Abstract][Full Text] [Related]
17. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
Haeger M; Bengtson A; Karlsson K; Heideman M
Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
[TBL] [Abstract][Full Text] [Related]
18. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg.
Marder SR; Chenoweth DE; Goldstein IM; Perez HD
J Immunol; 1985 May; 134(5):3325-31. PubMed ID: 3884709
[TBL] [Abstract][Full Text] [Related]
19. Complement ligand-receptor interactions that mediate biological responses.
Fearon DT; Wong WW
Annu Rev Immunol; 1983; 1():243-71. PubMed ID: 6242465
[No Abstract] [Full Text] [Related]
20. Biologically active products of complement and acute lung injury in patients with the sepsis syndrome.
Weinberg PF; Matthay MA; Webster RO; Roskos KV; Goldstein IM; Murray JF
Am Rev Respir Dis; 1984 Nov; 130(5):791-6. PubMed ID: 6497161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
